# Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunological-remission-in-pla2r-antibody-associated-membranous-nephropathy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anne-Els van de Logt,Karine Dahan,Alexandra Rousseau,Renate G. van der Molen,Hanna Dêbiec,Pierre Ronco,Jack F.M. Wetzels |
| Citations | 87 |
| DOI | 10.1016/j.kint.2017.12.019 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.kidney-international.org/article/S0085253818300863/pdf |
| OpenAlex ID | https://openalex.org/W2790603736 |
| PMID | 29571438 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Anne-Els van de Logt](https://scholariq.org/researchers/anne-els-van-de-logt/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.